Showing results (671-680 of 1,410) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|June 12, 2026
Reactive astrocytes mediate toxicity in iPSC derived dopaminergic neuronsNaroa Ibarra-Aizpurua, Jon Olano-Bringas, Benjamin Vallin, et al.NPJ Parkinson'S Disease|June 19, 2026
Discovery of lipid biomarkers for idiopathic Parkinson's disease in red blood cells and plasmaShaima Muhammed Nazaar, Anne M Roberts, Malcolm Horne, et al.NPJ Parkinson'S Disease|June 30, 2026
Global regional and national burden and trends of early-onset Parkinson's disease from 1990 to 2021Xuening Zhang, Hao Zhao, Zilin Li, et al.NPJ Parkinson'S Disease|June 26, 2026
Smartphone-derived digital motor measures to monitor progression in idiopathic REM sleep behavior disorderSarah Bouhadoun, Kirsten I Taylor, Stefan Lambrecht, et al.NPJ Parkinson'S Disease|July 4, 2026
Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson's diseaseLudo van Hillegondsberg, Shahzad Ahmad, Tanja Zerenner, et al.NPJ Parkinson'S Disease|July 4, 2026
Sleep and Parkinson's disease: a population-based study from the CHARLS cohortYunxi Wang, Wenqing Lv, Yaxin Li, et al.NPJ Parkinson'S Disease|July 3, 2026
Sternum-worn vibrotactile device in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot trialViktoria Azoidou, Essa Bhadra, Ellen Camboe, et al.NPJ Parkinson'S Disease|July 9, 2026
Monitoring nocturnal movement and sleep in Parkinson's disease: a systematic review of movement sensorsManon D Mijnsbergen, Paulien J van Tilborg, Luuk Kerckhaert, et al.NPJ Parkinson'S Disease|July 14, 2026
Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's diseaseThomas H Oosterhof, Eleanor Mitchell, Alberto Ascherio, et al.NPJ Parkinson'S Disease|July 20, 2026
APCDD1 shows high specificity for ventral midbrain dopaminergic progenitors in a cell surface marker benchmarking studyAlrik L Schörling, Alison Salvador, Pedro Rifes, et al.Pageof 141